If massive dilution occurs along with other financing, I'm curious as to what the worst case scenario pps would look like before climbing back before approval submission date. I believe the lowest MNKD has seen was $1.74 but I could be incorrect. It certainly seems as if the pps could only go higher assuming a minimally dilutive method of funding is pursued along with upcoming trial results either before or after q4...